Showing 17,701 - 17,720 results of 45,525 for search '(( 50 ((nn decrease) OR (a decrease)) ) OR ( 5 ((nm decrease) OR (mean decrease)) ))', query time: 0.99s Refine Results
  1. 17701
  2. 17702

    Antioxidant Carbocysteine Treatment in Obstructive Sleep Apnea Syndrome: A Randomized Clinical Trial by Kang Wu (160544)

    Published 2016
    “…The CPAP group also showed a decreased oxygen desaturation index and a significant increase in the mean oxygen saturation after treatment, but these increases were not observed in the carbocysteine group. …”
  3. 17703

    Chronic treatment with carvacrol improves passive avoidance memory in a rat model of Parkinson's disease by Hossein Haddadi (4895290)

    Published 2018
    “…The 6-OHDA-lesioned rats showed contralateral rotations towards the lesion side, which was accompanied by learning and memory deficits in a passive avoidance test and a decrease in tail withdrawal latency in a tail flick test at the end of week 6. …”
  4. 17704

    Vibration–induced enhancement of stick balancing skill as a function of vibration-induced amplitude lowering. by John G. Milton (223908)

    Published 2013
    “…Data is obtained from three subjects using three different vibration frequencies (15 Hz, 25 Hz, 50 Hz) on three different days. Relative survival is the same as defined in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0007427#pone-0007427-g003" target="_blank">Figure 3</a>. …”
  5. 17705

    PAMAM-DEN<sup>CYS</sup> induces trafficking of ΔF508-CFTR to plasma membrane in CF cells. by Scott Mackenzie Brockman (4433614)

    Published 2017
    “…(A, right panel; C) Immunoblotting of total protein extracts from CFBE41o- cells treated with PAMAM-DEN or PAMAM-DEN<sup>CYS</sup> shows a significant increase in ‘C form’ (p<0.05) in PAMAM-DEN<sup>CYS</sup> treated cells. …”
  6. 17706

    Image3_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.jpeg by Heather A. Ogana (11774297)

    Published 2023
    “…Therefore, we evaluated four compounds (827171, 827032, 826941, and 825226), previously generated from a large Artemis targeted drug screen. A biochemical assay using a purified Artemis:DNA-PKcs complex shows that the Artemis inhibitors 827171, 827032, 826941, 825226 have nanomolar IC50 values for Artemis inhibition. …”
  7. 17707

    Image1_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.jpg by Heather A. Ogana (11774297)

    Published 2023
    “…Therefore, we evaluated four compounds (827171, 827032, 826941, and 825226), previously generated from a large Artemis targeted drug screen. A biochemical assay using a purified Artemis:DNA-PKcs complex shows that the Artemis inhibitors 827171, 827032, 826941, 825226 have nanomolar IC50 values for Artemis inhibition. …”
  8. 17708

    HBV Infection in Relation to Consistent Condom Use: A Population-Based Study in Peru by Antonio Bernabe-Ortiz (90790)

    Published 2011
    “…Consistent condom use was associated with decreased risk of anti-HBc. Findings from this study emphasize the need of primary prevention programs (vaccination) especially in the jungle population, and imply that condom use promotion might be a potential strategy to prevent HBV infection.…”
  9. 17709

    Granulocyte Colony-Stimulating Factor Reduces Fibrosis in a Mouse Model of Chronic Pancreatitis by Wey-Ran Lin (615284)

    Published 2014
    “…We aimed to test the effect of G-CSF on fibrosis in a mouse model of CP.</p><p>Methods</p><p>CP was induced in C57Bl/6J mice by consecutive cerulein injection (50 µg/kg/day, 2 days a week) for 6 weeks. …”
  10. 17710

    Image2_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.jpeg by Heather A. Ogana (11774297)

    Published 2023
    “…Therefore, we evaluated four compounds (827171, 827032, 826941, and 825226), previously generated from a large Artemis targeted drug screen. A biochemical assay using a purified Artemis:DNA-PKcs complex shows that the Artemis inhibitors 827171, 827032, 826941, 825226 have nanomolar IC50 values for Artemis inhibition. …”
  11. 17711

    <i>Sox17</i> mutants exhibit a failure in emVE dispersal. by Manuel Viotti (27396)

    Published 2012
    “…<p>(A and B) Brightfield image and maximum intensity projection (MIP) of confocal <i>z</i>-stacks of wild-type <i>Afp::GFP</i> (panVE-reporter) embryo at EHF. …”
  12. 17712

    CCBs preserve normal R<sub>in</sub> against EC-Aβ in the granule cells. by Hamid Gholami Pourbadie (692631)

    Published 2015
    “…<p>A, R<sub>in</sub> was significantly decreased in the granule cells from Aβ treated rats compared to the control group. …”
  13. 17713
  14. 17714
  15. 17715

    Optical coherence tomography findings. by Eisuke Usui (12111855)

    Published 2024
    “…On OCT, layered plaques were more frequently present in the culprit vessels in the %hDPV-decrease group than in the %hDPV-increase group (85.0% vs. 50.6%, P = 0.01). …”
  16. 17716

    S1 Data - by Eisuke Usui (12111855)

    Published 2024
    “…On OCT, layered plaques were more frequently present in the culprit vessels in the %hDPV-decrease group than in the %hDPV-increase group (85.0% vs. 50.6%, P = 0.01). …”
  17. 17717

    Clinical demographics and angiographic findings. by Eisuke Usui (12111855)

    Published 2024
    “…On OCT, layered plaques were more frequently present in the culprit vessels in the %hDPV-decrease group than in the %hDPV-increase group (85.0% vs. 50.6%, P = 0.01). …”
  18. 17718

    Physiological parameters. by Eisuke Usui (12111855)

    Published 2024
    “…On OCT, layered plaques were more frequently present in the culprit vessels in the %hDPV-decrease group than in the %hDPV-increase group (85.0% vs. 50.6%, P = 0.01). …”
  19. 17719
  20. 17720